When mice carrying colorectal or ovarian cancer tumors with defects in the STING pathway were infected intratumorally with oncolytic HSV there were reductions in tumor size (Xia et al., 2016; De Queiroz et al., 2019). The gene discussed is STING1; the disease is ovarian cancer.